NM_001018109.3:c.556A>G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001018109.3(PIR):​c.556A>G​(p.Ile186Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000387 in 1,034,839 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000039 ( 0 hom. 2 hem. )

Consequence

PIR
NM_001018109.3 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.326

Publications

0 publications found
Variant links:
Genes affected
PIR (HGNC:30048): (pirin) This gene encodes a member of the cupin superfamily. The encoded protein is an Fe(II)-containing nuclear protein expressed in all tissues of the body and concentrated within dot-like subnuclear structures. Interactions with nuclear factor I/CCAAT box transcription factor as well as B cell lymphoma 3-encoded oncoprotein suggest the encoded protein may act as a transcriptional cofactor and be involved in the regulation of DNA transcription and replication. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
PIR Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07270223).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIRNM_001018109.3 linkc.556A>G p.Ile186Val missense_variant Exon 6 of 10 ENST00000380420.10 NP_001018119.1 O00625A0A024RBX6
PIRNM_003662.4 linkc.556A>G p.Ile186Val missense_variant Exon 6 of 10 NP_003653.1 O00625A0A024RBX6
PIR-FIGFNR_037859.2 linkn.608A>G non_coding_transcript_exon_variant Exon 5 of 15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIRENST00000380420.10 linkc.556A>G p.Ile186Val missense_variant Exon 6 of 10 1 NM_001018109.3 ENSP00000369785.5 O00625
PIRENST00000380421.3 linkc.556A>G p.Ile186Val missense_variant Exon 6 of 10 1 ENSP00000369786.3 O00625

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD2 exomes
AF:
0.00000547
AC:
1
AN:
182667
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000387
AC:
4
AN:
1034839
Hom.:
0
Cov.:
22
AF XY:
0.00000636
AC XY:
2
AN XY:
314497
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25155
American (AMR)
AF:
0.00
AC:
0
AN:
35132
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19003
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29945
South Asian (SAS)
AF:
0.0000760
AC:
4
AN:
52601
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40488
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3962
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
784495
Other (OTH)
AF:
0.00
AC:
0
AN:
44058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 29, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.556A>G (p.I186V) alteration is located in exon 6 (coding exon 5) of the PIR gene. This alteration results from a A to G substitution at nucleotide position 556, causing the isoleucine (I) at amino acid position 186 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
7.2
DANN
Benign
0.74
DEOGEN2
Benign
0.043
T;T
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.82
.;T
M_CAP
Benign
0.0067
T
MetaRNN
Benign
0.073
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.23
N;N
PhyloP100
0.33
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.21
N;N
REVEL
Benign
0.068
Sift
Benign
0.62
T;T
Sift4G
Benign
0.74
T;T
Polyphen
0.016
B;B
Vest4
0.086
MutPred
0.49
Gain of ubiquitination at K181 (P = 0.1446);Gain of ubiquitination at K181 (P = 0.1446);
MVP
0.75
MPC
0.023
ClinPred
0.065
T
GERP RS
3.1
Varity_R
0.13
gMVP
0.20
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs754259162; hg19: chrX-15444038; API